ATE444305T1 - Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungen - Google Patents
Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungenInfo
- Publication number
- ATE444305T1 ATE444305T1 AT04802607T AT04802607T ATE444305T1 AT E444305 T1 ATE444305 T1 AT E444305T1 AT 04802607 T AT04802607 T AT 04802607T AT 04802607 T AT04802607 T AT 04802607T AT E444305 T1 ATE444305 T1 AT E444305T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical formulations
- nmb1125 protein
- nmb1125
- protein
- formulations
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20030285A CU23237A1 (es) | 2003-12-03 | 2003-12-03 | PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS |
PCT/CU2004/000015 WO2005054281A2 (es) | 2003-12-03 | 2004-12-02 | Proteína nmb1125 y su uso en formulaciones farmaceuticas |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE444305T1 true ATE444305T1 (de) | 2009-10-15 |
Family
ID=40091628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04802607T ATE444305T1 (de) | 2003-12-03 | 2004-12-02 | Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungen |
Country Status (18)
Country | Link |
---|---|
US (1) | US7691971B2 (de) |
EP (1) | EP1693378B9 (de) |
KR (1) | KR20060123759A (de) |
CN (1) | CN1890260A (de) |
AR (1) | AR047263A1 (de) |
AT (1) | ATE444305T1 (de) |
AU (1) | AU2004294376A1 (de) |
BR (1) | BRPI0417309A (de) |
CA (1) | CA2547317A1 (de) |
CU (1) | CU23237A1 (de) |
DE (1) | DE602004023419D1 (de) |
ES (1) | ES2334138T3 (de) |
NO (1) | NO20063020L (de) |
NZ (1) | NZ547520A (de) |
PL (1) | PL1693378T3 (de) |
RU (1) | RU2336900C2 (de) |
WO (1) | WO2005054281A2 (de) |
ZA (1) | ZA200604556B (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
ES2304065T3 (es) * | 1998-05-01 | 2008-09-01 | Novartis Vaccines And Diagnostics, Inc. | Antigenos y composiciones de neisseria meningitidis. |
BR0010361A (pt) * | 1999-04-30 | 2003-06-10 | Chiron Corp | Seq ências genÈmicas de neisseria e uso destas |
-
2003
- 2003-12-03 CU CU20030285A patent/CU23237A1/es unknown
-
2004
- 2004-12-01 AR ARP040104481A patent/AR047263A1/es unknown
- 2004-12-02 KR KR1020067010712A patent/KR20060123759A/ko not_active Application Discontinuation
- 2004-12-02 AU AU2004294376A patent/AU2004294376A1/en not_active Abandoned
- 2004-12-02 RU RU2006123434/13A patent/RU2336900C2/ru not_active IP Right Cessation
- 2004-12-02 CA CA002547317A patent/CA2547317A1/en not_active Abandoned
- 2004-12-02 US US10/580,508 patent/US7691971B2/en not_active Expired - Fee Related
- 2004-12-02 DE DE602004023419T patent/DE602004023419D1/de active Active
- 2004-12-02 ES ES04802607T patent/ES2334138T3/es active Active
- 2004-12-02 EP EP04802607A patent/EP1693378B9/de active Active
- 2004-12-02 AT AT04802607T patent/ATE444305T1/de not_active IP Right Cessation
- 2004-12-02 WO PCT/CU2004/000015 patent/WO2005054281A2/es active Application Filing
- 2004-12-02 BR BRPI0417309-0A patent/BRPI0417309A/pt not_active IP Right Cessation
- 2004-12-02 PL PL04802607T patent/PL1693378T3/pl unknown
- 2004-12-02 CN CNA2004800358779A patent/CN1890260A/zh active Pending
- 2004-12-02 NZ NZ547520A patent/NZ547520A/xx unknown
-
2006
- 2006-06-02 ZA ZA200604556A patent/ZA200604556B/xx unknown
- 2006-06-28 NO NO20063020A patent/NO20063020L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2006123434A (ru) | 2008-01-10 |
NO20063020L (no) | 2006-09-01 |
CN1890260A (zh) | 2007-01-03 |
DE602004023419D1 (de) | 2009-11-12 |
PL1693378T3 (pl) | 2010-03-31 |
BRPI0417309A (pt) | 2007-09-11 |
AU2004294376A1 (en) | 2005-06-16 |
KR20060123759A (ko) | 2006-12-04 |
RU2336900C2 (ru) | 2008-10-27 |
NZ547520A (en) | 2009-07-31 |
EP1693378A2 (de) | 2006-08-23 |
ZA200604556B (en) | 2007-03-28 |
WO2005054281A3 (es) | 2005-08-04 |
CU23237A1 (es) | 2007-09-26 |
AR047263A1 (es) | 2006-01-11 |
CA2547317A1 (en) | 2005-06-16 |
US7691971B2 (en) | 2010-04-06 |
ES2334138T3 (es) | 2010-03-05 |
WO2005054281A2 (es) | 2005-06-16 |
US20070218000A1 (en) | 2007-09-20 |
EP1693378B9 (de) | 2010-05-19 |
EP1693378B1 (de) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
ATE480567T1 (de) | Hochkonzentrierter antikörper und proteinformulierungen | |
IS2504B (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
DE602004027354D1 (de) | SUBSTITUIERTE 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON- UND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATE UND DEREN VERWENDUNG BEI NEURODEGENERATIVEN KRANKHEITEN | |
IL163868A (en) | Hemiasterlin derivatives and pharmaceutical compositions comprising them | |
DE602005011818D1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
EP1491210A4 (de) | Therapeutisches arzneimittel unter verwendung von antikörper präsentierenden hohlen protein-nanoteilchen und hohle protein-nanoteilchen | |
DE602004022169D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
NO20042890L (no) | Farmasoytiske preparater og fremgangsmate for fremstilling derav | |
ATE456573T1 (de) | Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen | |
PL361364A1 (en) | Peptide and pharmaceutical composition as well as their therapeutic applications | |
GB0317877D0 (en) | Pharmaceutical combinations and formulations with improved stability | |
ITRM20020119A0 (it) | Composizioni contenenti plgf ad uso farmaceutico e cosmetico. | |
ATE444305T1 (de) | Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungen | |
EP1582586A4 (de) | Mit apoptose assoziiertes protein und dessen verwendung | |
GB0308317D0 (en) | Pharmaceutical preparations and their use | |
SI1610820T1 (sl) | Visokokoncentrirane formulacije protitelesa in proteinov | |
GB0409770D0 (en) | Pharmaceutical preparations and their uses | |
GB0326759D0 (en) | Pharmaceutical formulations and their preparation and use | |
GB0304362D0 (en) | Amino pyrimidine compounds and their use in medicine | |
FI20031798A (fi) | Uusia lääkeaineita ja valmisteita sekä diagnostisia aineita ja valmisteita sekä näiden käyttö | |
ITMI20042130A1 (it) | Composizione farmaceutica e cosmetica | |
SE0203245D0 (sv) | Methods and compositions usable in caract surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |